Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of Pol III promoters for controlled expression of therapeutic proteins

Use of Pol III promoters for controlled expression of therapeutic proteins

US Patent 9061058 · Granted Jun 23, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD5 specific T cell receptor cell or gene therapy2025
CD22-specific T cell receptors and adoptive T cell therapy for treatment of B ce2025
High avidity antigen recognizing constructs2025
High avidity antigen recognizing constructs2022
High avidity HPV T-cell receptors2022
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restric2020
Tumor specific T-cell receptors2020
High avidity antigen recognizing constructs2019
Epitope-tag surface expressed proteins and nucleic acids thereof2015
Epitope-tag surface expressed proteins and nucleic acids thereof2015
Generation of antigen specific T cells2013
Method of DNA vaccination2006